0000909518-10-000451.txt : 20100714 0000909518-10-000451.hdr.sgml : 20100714 20100713213043 ACCESSION NUMBER: 0000909518-10-000451 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20100713 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20100714 DATE AS OF CHANGE: 20100713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENTIVA HEALTH SERVICES INC CENTRAL INDEX KEY: 0001096142 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 364335801 STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15669 FILM NUMBER: 10951081 BUSINESS ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY STREET 2: SUITE 1400 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 7709516450 MAIL ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY STREET 2: SUITE 1400 CITY: ATLANTA STATE: GA ZIP: 30339 FORMER COMPANY: FORMER CONFORMED NAME: OLSTEN HEALTH SERVICES HOLDING CORP DATE OF NAME CHANGE: 19991001 8-K 1 mm07-1310_8k.htm FORM 8-K mm07-1310_8k.htm

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
 


 
FORM 8-K
 
 

 

 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
 
Date of Report (date of earliest event reported): July 13, 2010
 
 
 

 

Gentiva Health Services, Inc.
(Exact Name of Registrant as Specified in Its Charter)
 

 

 
         
Delaware
  
1-15669
  
36-4335801
(State or Other Jurisdiction of Incorporation)
  
(Commission File Number)
  
(IRS Employer Identification No.)
 
     
3350 Riverwood Parkway, Suite 1400
Atlanta, Georgia
  
 
30339-3314
(Address of principal executive offices)
  
(Zip Code)
 
Registrant’s telephone number, including area code: (770) 951-6450
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 

 
 

 


Item 8.01
  Other Events
 
On July 13, 2010, Gentiva Health Services, Inc., a Delaware corporation (“Gentiva”), issued a press release.  A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 8.01.

 
Item 9.01.
Financial Statements and Exhibits.
 
(d)
Exhibits.
 
 
Exhibit No.
Description
   
99.1
Press Release, dated July 13, 2010
 

 

 



 

 




 
2

 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: July 13, 2010
         
   
GENTIVA HEALTH SERVICES, INC.
     
   
By:
 
/S/    JOHN N. CAMPERLENGO        
       
John N. Camperlengo
       
Senior Vice President, General Counsel
       
Chief Compliance Officer and Secretary
 
 
 

 

 
3

 


 

EXHIBIT INDEX
 
 
Exhibit Number
Description
 
 
99.1
Press Release, dated July 13, 2010
 
 
 
 
 
 
 

 

 
4
 

EX-99.1 2 mm07-1310_8ke991.htm EX. 99.1 - PRESS RELEASE mm07-1310_8ke991.htm
 
Exhibit 99.1

Press Release


Financial and Investor Contact:
 
Eric Slusser
770-951-6101
eric.slusser@gentiva.com
 
or            Brandon Ballew
770-221-6700
brandon.ballew@gentiva.com
 
Media Contact:
 
Scott Cianciulli
Brainerd Communicators
212-986-6667
cianciulli@braincomm.com


FOR IMMEDIATE RELEASE

Gentiva® Health Services Schedules Second Quarter Earnings Call and Web Cast for
Thursday, July 29, 2010

Company Notified By Securities and Exchange Commission
of Inclusion in Ongoing Industry Investigation

Atlanta, GA, July 13, 2010 -- Gentiva Health Services, Inc. (Nasdaq: GTIV), a leading provider of home health and hospice services, announced today that it has scheduled a conference call and web cast on Thursday, July 29, 2010, at 10:00 a.m. EDT to discuss operating results for the second quarter ended July 4, 2010. Gentiva plans to issue its financial news release the morning of July 29 before pre-market trading.

The Company separately announced that today it has been informed by the Securities and Exchange Commission that the Commission has commenced an investigation relating to Gentiva’s participation in the Medicare Home Health Prospective Payment System (HH PPS).  The Company believes the investigation is similar to the Commission’s ongoing investigations and the Senate Finance Committee inquiry previously disclosed by Gentiva and other home health companies.  The Commission requested that the company preserve all documents from January 1, 2000 to the present relating to its participation
 
3350 Riverwood Parkway, Suite 1400, Atlanta, GA 30339
 
 
 

 
 
 
in the HH PPS and was further advised that a subpoena would be forthcoming in the next few days. The Company plans to comply with the document request and cooperate with the investigation.

The July 29, 2010 conference call is open to investment analysts and managers, Company shareholders and others interested in Gentiva Health Services. Instructions for participation in the conference call follow:
·  
Event: Gentiva Health Services' second quarter 2010 conference call.
 
·  
Date and Time: Thursday, July 29, 2010, 10:00 a.m. EDT.
 
·  
Instructions: Participants in the United States, Canada and international locations may call (973) 935-2408 and reference call # 86731520.
 
·  
Web Cast URL: http://investors.gentiva.com/events.cfm.
 
·  
Replay: A replay of the call will be available on July 29, beginning at approximately 1 p.m. EDT, and will remain available continuously through August 13. To listen to a replay of the call from the United States, Canada or international locations, dial (800) 642-1687 or (706) 645-9291 and enter the following PIN at the prompt: 86731520. Visit http://investors.gentiva.com/events.cfm to access the web cast archive.
 
·  
Transcript: A transcript of the call, including questions and answers, is expected to be available on Gentiva's web site within 48 hours after its conclusion.

 
About Gentiva Health Services, Inc.
 
 
Gentiva Health Services, Inc. is a leading provider of home health and hospice services, delivering innovative, high quality care to patients across the United States. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; and other therapies and services. For more information, visit Gentiva's web site, http://www.gentiva.com, and its investor relations section at http://investors.gentiva.com. GTIV-E
 

Forward-Looking Statement

Certain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These factors include, among others, the following: economic and business conditions, including the ability to access capital markets; demographic changes; changes in, or failure to comply with, existing governmental regulations; the impact on our Company of recently passed healthcare reform legislation and its subsequent implementation through governmental regulations; changes
 
 
 
2

 
 
 
in Medicare and Medicaid reimbursement levels; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to natural disasters, pandemic outbreaks, or terrorist acts; ability to successfully integrate the operations of acquisitions the Company may make and achieve expected synergies and operational efficiencies within expected time-frames; effect on liquidity of the Company's debt service requirements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended January 3, 2010.

# # #
 
 
 
 
 
 
 
 
 
 
 
 


 
3

 

GRAPHIC 3 gentiva_logo.jpg begin 644 gentiva_logo.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#WN>>&UMY) M[B5(H8U+.[G"J!U)->)^*_C+?7TUU9^$D2*"!"[WTP&]U!Y**W`'/?)/H*3X MR^+#?:M'X1M[M;>UC`DO9#T9\;E0^PX/U(]*\G16GCMKR\MV^P1$0,T(`)QD MX^O/6M(QZL]7!X.+BJD^ILW&N?VG9Z?+?Z[K5]?27.+NU,C%1'GC9DXW$=/< M_G+_`&E;:;>:T;/6=>TN2)A]AM][*S'N),'C\>WK6A!;ZPGA'P]/Y]A9:2FH M[H+LY\Z,EF^:3^$C@_D,XJU<1ZU(_C26SO=-U.U,2BZNI$`8@*>(]O&0`1UQ MP,.^\2;3M3`*`$XAG/`'/KC:1[J>QI./8YL7@XN+G3T:/H:BJ& MHZS9:48Q=2%6?H%4L<>O'^35R&:.XA2:%P\;@,K#N*S/''T5@ZWXQT70)/)O M;K,^,F&)=S`>_8?C61:_%'P[<2A'-W`#_')$"/\`QTFE=`=K14=O<0W=ND]O M*DL+C*NC9##V-8>L>,]&T*^-G?2RK,%#X6(L,'IR*=P.@HKC_P#A9GAK_GXG M_P"_#5U%C>PZC8P7EN289D#H2,'!]J2:>P%BBL*P\8:/J.KOI<$[_:E++M=" MH)7J`>YZ_E6[3`**R[#Q#I^I:K>:;;.YN;0D2@H0!@XX/?FJ&J^.-$T;49;" M\FF6>/&X+$2.0".?H:5T!T=%(VN5TZ21S M;A#)O0KC=NQU_P!TT70&S169;Z]876O7.C1.YO;9-\BE"`!\O?O]X5'+XDTZ M#Q!'HDKR)>RC*`H=K#!/#=.Q'UIW`UZ**RKGQ%I]KKEOH\CR&]G`9$1"1@YZ MGMT)H`U:**R+CQ-I5KKT.C2SD7LN-JA20":MW^G6ME<>+X/^$(NH]L">41MV1?)UX;&,_/\I/3M573KR&RT M/P_]E\<>2(-1.V!D0^0NYQN(QG&#_%\OSU=U'4!=R^+IF\>;SY"JB`1@3@1] M!@8ZG;E,')YI;&#YN?R^??\`K_AC#D725U?19U\'WXT^[M=OV<.?])?'RLN# MSCKSCKGZX(C6RT>],>AWD.I65\KM>ER1;+GY488QG(_$_@*Z&:6P&N:%:Q^- MI1:6MJ6CGV`_9GVX"C''(`&#T`QWKGQ@WY&OSR7U[?!7L-K8N1P1(3T! MR>GM]*I'1&[W_4^E[[2%\0VMK>I*L)EB1V5T+J?E;;W'3S&]CGD&G:[?'PQX M2N+B)M\T281F'WI&/WB.G4YQ6O8V_P!CT^VML[O)B6//K@`5A>.["34/!][' M"I:2,+*%`Y(4@G],U@T?.NU]#+\!^%[6+3(M:OXUN=0N\S!Y1NV`GC&>YZD^ M^*Z75K+2-2@:UU-;9P1C]X0&7W!ZC\*SO`NK0ZIX5M`CCSK9!#*F>5(X!^A& M#_\`JJKXH\&:1J0OM6N%F^U"`ME9,#*KQQ^%`CIK"&TMK**"Q6);:,;46(_* M*X#5?L8^+MO]O\C[/]E^;S\;,[6QG/%:WPRQ_P`(9#C_`)[29_.L76]+M-9^ M*\-C?1F2WDM>=$%ZL-SD@#UX!'Y=Z]1\+>((O$>BQW:[5G7Y)XQ_"_^!ZBN;^'7_(7 M\3?]?0_]"DJOJL3^`_%B:S;JQT?4&V74:CA&Z\#\R/\`@0J(NRN,D\'?\E$\ M3_[[?^C*[B?2M.N9C-/86LLK=7DA5B?Q(KA?!4B2_$#Q))&ZO&[,RLIR""_! M%>BU4>HCSCP[I]E-\1O$%O+9VSPQK\D;1*57E>@QQ7?VUC9V1?[+:P0;\;O* MC"[L=,XZ]3^=<1X8_P"2G>)/]W^JUW]-`<#HW_)8-<_Z]/\`XS1\2[*6"/3_ M`!!:#$]C*`Q`SP2"I/L&&/\`@5+HW_)8-<_Z]/\`XS78ZKI\6JZ5=6$P&R>, MID]CV/X'!J$KIC'V=[#>Z;!?1L!#-$)02>@(SS7#>"D_M_Q7J_B:53Y8?R;; M<.@QC\PH4?\``C6%:>))=,^'VI:+,=NH0SFT1.X5R=WY8^:V2'R2"Y^88P<_)WYHW8CJ],O(_$OAJVNTVF4I)&XR& M!KPGQ3\']7T2:[N_#2K?V,T;*;9P#-$IZA<_>QV(Y]CUK6,NC/6P>+BXJG-V M:V,**?5QX2\-".PT^[TW^T2+:'&9I6#-P^?E&>>1[9JY)FV]U:ZG8:M'=%KJ5P4VQYX**>0P M&/Q!]JE8Z/=WVM1)_:NJ7,P`T^?DN[9Y+CJ>W;MV-%M#J<5O_6_W%!")))=, MTN?-OC'Z# MUI_A;X2:_P"($M1K47]E:;#D@L@$\@)R0%[?5NGH:]]TC2+'0M,AT[3K=8+: M$85%[^I)[D]S1*70Y\7C(QBX0=VR[11169XQPVH?#YX-1;4?#>I-IL[9+1<[ M/H,=![$$?2HI?#/C?4(FM[_Q-"L###>2F"1W'"K_`#KOJ*GE0&5X=T.+P[H\ M>GQ3/,%8L7<`9).3P.@K!U_P?J6I>)!K&G:JME*(A&IV$L.N>?QKLZ*JP'"? M\(IXO_Z&Y_\`O@UUNCVMW9:5!;WUV;NY3.^8C&[))_EQ5ZBE9`PNTW0S+M..H]"/<'FK=%"26B`X M[P=X+G\+WUS/+>QW`FC"`(A7&#G/6NQHHIV`YS2O#4NG>+-3UEKE'CO5P(PI M!7D'K^%='110!SECX:FM/&VH:^URC174/EK"%.5^YSG_`(`?SKHZ**`.-N_` M45UXT36S.@M]ZRR6^SEG`]?0D`G\:[*BB@#EXO"L[^-Y/$%[=1RHJE;>%5/[ MOC`Y^A8_4UU%%%)*P'+:WX4GOO$]AKMA=QV]Q;@"170D2`'V]02#[8KJ:**8 M!1110!A^*?\`D&_C_456\(_\>\_^_P#T%%%:_P#+OYG5_P`N/Z[G2T445D